pharmaceuticals

Moderna (MRNA) set to take advantage of opportunity in vaccines

September 21, 2020

Illumina (ILMN) is uniquely placed to offer long-term returns. Here’s why

September 18, 2020

Humana (HUM) can offer long-term returns despite high valuation

September 15, 2020

COVID-19 vaccine development: A look at some of the pharma companies and their progress

September 15, 2020

Medtronic (MDT) revisits business strategy even as recovery gathers steam

August 26, 2020

Will da Vinci power help Intuitive Surgical (ISRG) beat COVID blues?

August 25, 2020

Stable demand should help PetMed (PETS) emerge stronger from pandemic

August 19, 2020

CureVac (CVAC): Another COVID-19 stock that attracted investors

August 18, 2020

Transcript

Veru Inc. (VERU) Q3 2020 Earnings Call Transcript

August 13, 2020

Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021

August 11, 2020

Oncology to COVID-19: Karyopharm (KPTI) CEO on what’s ahead

August 7, 2020

Transcript

Cardinal Health Inc. (CAH) Q4 2020 Earnings Call Transcript

August 7, 2020

Transcript

Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript

August 7, 2020

Transcript

Karyopharm Therapeutics Inc. (KPTI) Q2 2020 Earnings Call Transcript

August 6, 2020

Transcript

Mylan N.V. (MYL) Q2 2020 Earnings Call Transcript

August 6, 2020

Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings

August 6, 2020

Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook

August 5, 2020

Amarin (AMRN) maintains revenue growth despite COVID-19 headwinds

August 4, 2020

Transcript

McKesson Corp. (MCK) Q1 2021 Earnings Call Transcript

August 3, 2020

Strong performance of oncology products bode well for AbbVie (ABBV) going forward

August 3, 2020

Transcript

Merck & Co., Inc. (MRK) Q2 2020 Earnings Call Transcript

July 31, 2020